Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light

被引:86
作者
Basuki, Johan S. [1 ]
Qie, Fengxiang [2 ]
Mulet, Xavier [1 ]
Suryadinata, Randy [1 ]
Vashi, Aditya V. [1 ]
Peng, Yong Y. [1 ]
Li, Lingli [3 ,4 ]
Hao, Xiaojuan [1 ]
Tan, Tianwei [2 ]
Hughes, Timothy C. [1 ]
机构
[1] CSIRO Mfg, Bayview Ave, Clayton, Vic, Australia
[2] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China
[3] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China
[4] Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China
关键词
agarose; drug delivery; gold nanoparticles; macular degeneration; photothermal effect; CONTROLLED DRUG-DELIVERY; ALGINATE MICROCAPSULES; POSTERIOR SEGMENT; VEGF; RANIBIZUMAB; BEVACIZUMAB; MECHANISMS; SYSTEMS;
D O I
10.1002/anie.201610618
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The use of biomacromolecular therapeutics has revolutionized disease treatment, but frequent injections are required owing to their short half-life in vivo. Thus there is a need for a drug delivery system that acts as a reservoir and releases the drug remotely "on demand". Here we demonstrate a simple light-triggered local drug delivery system through photo-thermal interactions of polymer-coated gold nanoparticles (AuNPs) inside an agarose hydrogel as therapeutic depot. Localized temperature increase induced by the visible light exposure caused reversible softening of the hydrogel matrix to release the pre-loaded therapeutics. The release profile can be adjusted by AuNPs and agarose concentrations, light intensity and exposure time. Importantly, the biological activity of the released bevacizumab was highly retained. In this study we demonstrate the potential application of this facile AuNPs/hydrogel system for ocular therapeutics delivery through its versatility to release multiple biologics, compatibility to ocular cells and spatiotemporal control using visible light.
引用
收藏
页码:966 / 971
页数:6
相关论文
共 30 条
[11]   A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies [J].
Kennedy, Laura C. ;
Bickford, Lissett R. ;
Lewinski, Nastassja A. ;
Coughlin, Andrew J. ;
Hu, Ying ;
Day, Emily S. ;
West, Jennifer L. ;
Drezek, Rebekah A. .
SMALL, 2011, 7 (02) :169-183
[12]   Ocular delivery of macromolecules [J].
Kim, Yoo Chun ;
Chiang, Bryce ;
Wu, Xianggen ;
Prausnitz, Mark R. .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :172-181
[13]  
Matteini P., 2013, ANGEW CHEM, V125, P6072
[14]   Photothermally Activated Hybrid Films for Quantitative Confined Release of Chemical Species [J].
Matteini, Paolo ;
Tatini, Francesca ;
Luconi, Lapo ;
Ratto, Fulvio ;
Rossi, Francesca ;
Giambastiani, Giuliano ;
Pini, Roberto .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (23) :5956-5960
[15]   Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab [J].
Meyer, C. H. ;
Holz, F. G. .
EYE, 2011, 25 (06) :661-672
[16]   Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies [J].
Mitragotri, Samir ;
Burke, Paul A. ;
Langer, Robert .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :655-672
[17]  
Ochs M., 2013, ANGEW CHEM, V125, P723
[18]   Light-Addressable Capsules as Caged Compound Matrix for Controlled Triggering of Cytosolic Reactions [J].
Ochs, Markus ;
Carregal-Romero, Susana ;
Rejman, Joanna ;
Braeckmans, Kevin ;
De Smedt, Stefaan C. ;
Parak, Wolfgang J. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (02) :695-699
[19]   Photocontrolled release using one-photon absorption of visible or NIR light [J].
Olejniczak, Jason ;
Carling, Carl-Johan ;
Almutairi, Adah .
JOURNAL OF CONTROLLED RELEASE, 2015, 219 :18-30
[20]   Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab [J].
Papadopoulos, Nicholas ;
Martin, Joel ;
Ruan, Qin ;
Rafique, Ashique ;
Rosconi, Michael P. ;
Shi, Ergang ;
Pyles, Erica A. ;
Yancopoulos, George D. ;
Stahl, Neil ;
Wiegand, Stanley J. .
ANGIOGENESIS, 2012, 15 (02) :171-185